Grass J, Grupp K, Kluth M, Hube-Magg C, Simon R, Kemper M
Cancers (Basel). 2024; 16(8).
PMID: 38672555
PMC: 11047823.
DOI: 10.3390/cancers16081473.
Olah O, Majlat E, Koszo R, Vereb Z, Voros A
Pathol Oncol Res. 2023; 28:1610598.
PMID: 36685105
PMC: 9849231.
DOI: 10.3389/pore.2022.1610598.
Zurawski J, Talarska P, de Mezer M, Kaszkowiak K, Chalcarz M, Iwanik K
Gastroenterol Hepatol Bed Bench. 2022; 15(1):24-31.
PMID: 35611259
PMC: 9123638.
Mizerska-Kowalska M, Sawa-Wejksza K, Slawinska-Brych A, Kandefer-Szerszen M, Zdzisinska B
Clin Transl Oncol. 2021; 23(7):1405-1414.
PMID: 33537866
DOI: 10.1007/s12094-020-02537-x.
Louhichi T, Saad H, Dhiab M, Ziadi S, Trimeche M
BMC Cancer. 2018; 18(1):49.
PMID: 29306324
PMC: 5756378.
DOI: 10.1186/s12885-017-3951-8.
Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis.
Mishra D, Singh S, Narayan G
Mol Biol Int. 2016; 2016:4328697.
PMID: 27965895
PMC: 5124668.
DOI: 10.1155/2016/4328697.
Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development.
Mizerska-Kowalska M, Bojarska-Junak A, Jakubowicz-Gil J, Kandefer-Szerszen M
Tumour Biol. 2016; 37(10):13355-13368.
PMID: 27460083
PMC: 5097095.
DOI: 10.1007/s13277-016-5248-y.
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.
Chatalic K, Konijnenberg M, Nonnekens J, de Blois E, Hoeben S, de Ridder C
Theranostics. 2016; 6(1):104-17.
PMID: 26722377
PMC: 4679358.
DOI: 10.7150/thno.13580.
Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer.
Oo H, Sentani K, Mukai S, Hattori T, Shinmei S, Goto K
Gastric Cancer. 2015; 19(2):443-452.
PMID: 26223471
DOI: 10.1007/s10120-015-0511-2.
Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?.
Mizerska-Dudka M, Kandefer-Szerszen M
Arch Immunol Ther Exp (Warsz). 2014; 63(3):197-205.
PMID: 25193979
PMC: 4429139.
DOI: 10.1007/s00005-014-0311-0.
Prognostic significance of the combined expression of neutral endopeptidase and dipeptidyl peptidase IV in intrahepatic cholangiocarcinoma patients after surgery resection.
Zhu J, Guo X, Qiu B, Li Z, Xia N, Yang Y
Onco Targets Ther. 2014; 7:297-304.
PMID: 24570591
PMC: 3933717.
DOI: 10.2147/OTT.S57355.
Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
Shiratsu K, Higuchi K, Nakayama J
Cancer Sci. 2013; 105(1):126-33.
PMID: 24138592
PMC: 4317868.
DOI: 10.1111/cas.12305.
The contribution of cell phenotype to the behavior of gastric cancer.
Solcia E, Klersy C, Vanoli A, Grillo F, Manca R, Tava F
Gastric Cancer. 2013; 16(4):462-71.
PMID: 23329390
DOI: 10.1007/s10120-012-0208-8.
Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer.
Khanh D, Mekata E, Mukaisho K, Shimizu T, Tatsuta T, Sugihara H
Int J Clin Oncol. 2011; 17(3):240-9.
PMID: 21773689
DOI: 10.1007/s10147-011-0281-8.
Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases.
Divito S, Morelli A, Larregina A
Immunol Res. 2011; 50(2-3):195-201.
PMID: 21717076
DOI: 10.1007/s12026-011-8219-9.
CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.
Gurel D, Kargi A, Karaman I, Onen A, Unlu M
Pathol Oncol Res. 2011; 18(2):153-60.
PMID: 21681600
DOI: 10.1007/s12253-011-9421-8.
Prognostic role of CD10⁺ myeloid cells in association with tumor budding at the invasion front of colorectal cancer.
Khanh D, Mekata E, Mukaisho K, Sugihara H, Shimizu T, Shiomi H
Cancer Sci. 2011; 102(9):1724-33.
PMID: 21599811
PMC: 11158074.
DOI: 10.1111/j.1349-7006.2011.01987.x.
Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.
Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, Berisa A, Gil D, Embade N
Proteomics Clin Appl. 2010; 4(4):416-25.
PMID: 20535238
PMC: 2882112.
DOI: 10.1002/prca.200900103.
CD10 expression in urothelial carcinoma of the bladder.
Bahadir B, Behzatoglu K, Bektas S, Bozkurt E, Ozdamar S
Diagn Pathol. 2009; 4:38.
PMID: 19917108
PMC: 2780995.
DOI: 10.1186/1746-1596-4-38.
Discovery of dominant and dormant genes from expression data using a novel generalization of SNR for multi-class problems.
Tsai Y, Lin C, Tseng G, Chung I, Pal N
BMC Bioinformatics. 2008; 9:425.
PMID: 18842155
PMC: 2620271.
DOI: 10.1186/1471-2105-9-425.